In the present study, neuronal cells differentiated from the AD hPSC line used for the generation of AD COs were found to robustly express Aβ and phosphorylated tau, and the levels of Aβ and phosphorylated tau were significantly attenuated by the treatment with BSI and CE. The gene discussed is MAPT; the disease is Alzheimer disease.